Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney
at www.tipranks.com (Tue, 3-Feb 6:26 AM)
ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating
at www.tipranks.com (Mon, 2-Feb 9:46 PM)
ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans
at www.tipranks.com (Mon, 2-Feb 4:40 PM)
